U.S. Food et al., 1994-05-31: FDA freedom-of-information summary for the zoo-animal supplement, including a target-animal safety study at ten times the recommended dose. The only findings were reduced appetite in two big cats and loose stools in field trials.
In one jaguar and the lion, there were periods of inappentence (sic) following the initial consumption of fenbendazole at ten times the recommended level.
6
U.S. Food et al., 1994-05-31: FDA freedom-of-information summary for the zoo-animal supplement, including a target-animal safety study at ten times the recommended dose. The only findings were reduced appetite in two big cats and loose stools in field trials. Regulatory record with an embedded target-animal safety study: 5 big cats (2 jaguars, 1 puma, 1 lion, 1 Siberian tiger) at 100 mg/kg/day for 6 days, and 3 polar bears at 100 mg/kg/day for 4 days, against a 10 mg/kg label dose; no controls, animals served as their own reference; observations only, no necropsy. Country: USA (zoo populations). Funder: sponsor (Hoechst-Roussel). Comparator: none (dose escalation against label dose). Bearing PARTLY SUPPORTS: tolerability at 10x for a short course is real evidence of a wide acute margin, but the study was uncontrolled and measured almost nothing. Excerpt is on PDF page 6 (printed page 6 of the 8-page summary). Study type: regulatory record.
